Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia.
Saved in:
| Title: | Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemia. |
|---|---|
| Authors: | Tremblay CS; Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. cedric.tremblay@umanitoba.ca.; Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada. cedric.tremblay@umanitoba.ca.; Children's Hospital Research Institute of Manitoba (CHRIM), Winnipeg, MB, Canada. cedric.tremblay@umanitoba.ca.; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia. cedric.tremblay@umanitoba.ca., Saw J; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Yan F; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Bioinformatics Division, Walter and Eliza Hall Institute (WEHI) of Medical Research, Parkville, VIC, Australia., Boyle JA; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Amarasinghe O; Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.; Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada., Abdollahi S; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Vo ANQ; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Shields BJ; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia., McCalmont H; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia., Evans K; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia., Steiner A; Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada.; Community and Researcher Engagement (CaRE) program, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Women in Lymphoma, Lymphoma Australia, Brisbane, QLD, Australia., Parsons K; Community and Researcher Engagement (CaRE) program, School of Translational Medicine, Monash University, Melbourne, VIC, Australia., McCormack MP; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Powell DR; Monash Bioinformatics Platform, Monash University, Clayton, VIC, Australia., Wong NC; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Monash Bioinformatics Platform, Monash University, Clayton, VIC, Australia., Jane SM; Department of Medicine, School of Translational Medicine, Monash University, Melbourne, VIC, Australia., Lock RB; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health, UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, NSW, Australia., Curtis DJ; Australian Centre for Blood Diseases (ACBD), School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Department of Clinical Haematology, Alfred Hospital, Prahran, VIC, Australia. |
| Source: | Leukemia [Leukemia] 2025 Mar; Vol. 39 (3), pp. 577-589. Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
